Acurx Pharmaceuticals (ACXP) Misses Q3 EPS by 2c

Acurx Pharmaceuticals (NASDAQ: ACXP) reported Q3 EPS of ($0.17), $0.02 worse than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Acurx Pharmaceuticals (ACXP) click here.

You May Also Be Interested In

• Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
• Saba Capital funds reapprove merger plan targeting Q4 2026 close
• Infleqtion, Inc (INFQ) PT Raised to $22 at Citi